벤조피란 유도체의 제조 방법
    23.
    发明授权
    벤조피란 유도체의 제조 방법 失效
    制备苯并吡喃衍生物的方法

    公开(公告)号:KR1019950009864B1

    公开(公告)日:1995-08-29

    申请号:KR1019910024354

    申请日:1991-12-26

    Abstract: The cpd. of formula (I-a) is prepd. by (a) reacting ketone derivatives of formula (II) with trifluorosulfonic acid anhydride and ter-amine, or making the ketone derivatives (II) to enolate with a base and then reacting N-phenyl trifluoromethane sulfonimide to convert to the vinyl triflate derivs. of formula (III); and (b) reacting the derivs. (III) with pyridyl trialkyline derivs. of formula (IV) in the presence of palladium catalyst and chloride. In the formulas, R1 is -CN, -NO2, -OCX1X2X3, -NH2, -NHSO2Ra etc; X1, X2, and X3 are F, Cl or H; R3 is H or C1-6 alkyl or phenyl; R4 is C1-4 alkyl.

    Abstract translation: cpd。 的式(I-a)是制备的。 通过(a)使式(II)的酮衍生物与三氟磺酸酐和三胺反应,或使酮衍生物(II)与碱烯醇化,然后使N-苯基三氟甲磺酰亚胺反应转化成三氟甲磺酸乙烯酯衍生物。 的式(III); 和(b)使衍生物反应。 (III)与吡啶基三烷基衍生物。 式(Ⅳ)化合物在钯催化剂和氯化物存在下反应。 式中,R1为-CN,-NO2,-OCX1X2X3,-NH2,-NHSO2Ra等; X1,X2和X3分别为F,Cl或H; R3是H或C1-6烷基或苯基; R4是C1-4烷基。

    벤조피란 유도체와 그의 제조방법
    25.
    发明授权
    벤조피란 유도체와 그의 제조방법 失效
    新型苯并噻吩衍生物及其制备方法

    公开(公告)号:KR1019930011040B1

    公开(公告)日:1993-11-20

    申请号:KR1019900019034

    申请日:1990-11-23

    Abstract: Novel benzopyran derivatives of formula (I) are prepared by O- nitration at C-3 hydroxy group of cromakalim of formula (II) in the anhydride acetic acid or C.H2SO4. In the formula (I), R1 R2=H, NO2, nitryl; R3= 2-oxo-1-pyrrolidinyl. Compound (I) are useful as antihypertensive and vasodilating agents.

    Abstract translation: 式(I)的新型苯并吡喃衍生物通过在酸酐乙酸或C.H 2 SO 4中通过式(II)的cromakalim的C-3羟基进行O-硝化来制备。 在式(I)中,R1R2 = H,NO2,硝基; R3 = 2-氧代-1-吡咯烷基。 化合物(I)可用作抗高血压药和血管舒张剂。

    인단 유도체와 그의 제조방법
    26.
    发明授权
    인단 유도체와 그의 제조방법 失效
    制备印度衍生物的方法

    公开(公告)号:KR1019930006765B1

    公开(公告)日:1993-07-23

    申请号:KR1019910001326

    申请日:1991-01-26

    Abstract: Indane derivs. of formula (I) are new. In (I), R1= nitro, nitrile, halogen, amino, CF3, -(C=NH)-OMe, -NHCOCS3, -NHCSCX3, - COR4, -OCX3 OR -CSR4; X=H or halogen; R4=H, amino, lower alkyl or alkoxy, or opt. substd. phenyl; R2=-NO5R6, a gp. of formula (II), a gp. of formula (III), a gp. of formula (IV), etc.; R5 and R6 each=H, lower alkyl, cyclopropyl, cyclopropyl methyl or benzyl; n = 1 or 2; Y=CH2, O, S or -NR4; R3=H, OH, nitrooxy, formyloxy, alkanoyloxy, haloalkanoyloxy, alkoxycarbonyl, aroyloxy or carbamoyloxy. The cpds. (2) may be used in the treatment of hypertension.

    Abstract translation: indane派生。 式(I)的化合物是新的。 在(I)中,R1 =硝基,腈,卤素,氨基,CF3, - (C = NH)-OMe,-NHCOCS3,-NHCSCX3,-COR4,-OCX3或-CSR4; X = H或卤素; R4 = H,氨基,低级烷基或烷氧基,或选择。 substd。 苯基; R2 = -NO5R6,gp。 的式(II),gp。 的式(III),gp。 的式(IV)等; R5和R6各自为H,低级烷基,环丙基,环丙基甲基或苄基; n = 1或2; Y = CH 2,O,S或-NR 4; R3 = H,OH,硝基氧基,甲酰氧基,烷酰氧基,卤代烷酰氧基,烷氧基羰基,芳氧基或氨基甲酰氧基。 cpds。 (2)可用于治疗高血压。

    이소옥사졸리딘 유도체와 그의 제조방법
    27.
    发明授权
    이소옥사졸리딘 유도체와 그의 제조방법 失效
    ISOOXAZOLIDINE衍生物及其制备方法

    公开(公告)号:KR1019920003608B1

    公开(公告)日:1992-05-04

    申请号:KR1019890010565

    申请日:1989-07-26

    Abstract: 5-[4-[5-[3-(4-Fluorophenyl) isoxazolidyl phenyl -(1H)tetrazole of formula (I) is new. Also claimed is the prepn. of (I) which comprises (a) reacting an aldehyde deriv. of formula (II) with a hydroxy amine cpd. to obtain an oxime deriv. of formula (III), (b) halogenating (III) and reacting the obtd. halogenated oxime deriv. with a styrene cpd. of formula (IV), and (c) reacting the obtd. cpd. with an azide cpd. to form (I). The cpd. (I) has an effect on blood pressure and on the contractility of the cardiac muscle.

    Abstract translation: 式(I)的5- [4- [5-(3-氟-4-苯基)异恶唑烷基苯基 - (1H)四唑是新的。 还声称是prepn。 (I),其包含(a)使醛衍生物反应。 的式(II)与羟基胺cpd反应。 得到肟衍生物。 (III),(b)卤化(III)并使该反应物反应。 卤代肟衍生物。 与苯乙烯cpd。 式(Ⅳ),(c)使该反应物反应。 CPD。 与叠氮化合物cpd。 形成(I)。 cpd。 (I)对血压和心肌的收缩力有影响。

Patent Agency Ranking